LivaNova Hits Back In €21M Suit Over Heart Biz Acquisition
Medical giant LivaNova has hit back against a €21 million ($22.5 million) lawsuit from Gyrus Capital over a soured heart technology deal, saying that the Swiss private equity firm knew about...To view the full article, register now.
Already a subscriber? Click here to view full article